SCHOEMAKER KATHLEEN K
Insider CIK 1207789 · ACHN 10% owner · GKOS 10% owner · ALIM 10% owner · MRNS 10% owner · OCRX 10% owner · AKAO 10% owner · RGDO 10% owner · CADX 10% owner · LIFE 10% owner · ALDX 10% owner · CLCD 10% owner · VCYT 10% owner · DRNA 10% owner · EVOK 10% owner · ESPR 10% owner · TNDM 10% owner · CLVS 10% owner · OTIC 10% owner · RVA 10% owner · DRTX 10% owner · ATRA 10% owner · NEOT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EVOK Evoke Pharma Inc | S Sale | 2015-08-18 | 2015-08-20 | 11,836 | $7.02 | $83.1K | 1,052,328 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-08-18 | 2015-08-20 | 202 | $7.02 | $1.4K | 17,947 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 14,041 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 105,128 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 440,178 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-07-01 | 20,470 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 585,958 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 925,926 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 4,371 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 2,130 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 589,100 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 286,983 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 14,041 | — | $0 | 14,041 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 2,057,190 | — | $0 | 2,057,190 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-07-01 | 8,700 | $18.00 | $156.6K | 2,068,960 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-07-01 | 20,470 | $7.65 | $156.6K | 2,077,660 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 6,501 | — | $0 | 6,501 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 876,083 | — | $0 | 876,083 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 1,506,901 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 12,143,933 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 887,073 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 90,110 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 11,182 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 6,581 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-12 | 1,807,820 | — | $0 | 1,807,820 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-12 | 13,414 | — | $0 | 13,414 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 464,756 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 939,289 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 798,188 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,954 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,565 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-11 | 2,202,233 | — | $0 | 2,245,902 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-11 | 3,519 | — | $0 | 3,519 | SEC↗ |
| TBRA Regado Biosciences Inc | P Buy | 2015-05-04 | 2015-05-06 | 277,777 | $10.62 | $2.95M | 3,553,322 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | J Other | 2015-05-04 | 2015-05-06 | 36,187 | — | $0 | 38,094 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-16 | 2015-04-16 | 554 | $7.07 | $3.9K | 18,149 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-16 | 2015-04-16 | 32,411 | $7.07 | $229.1K | 1,064,164 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-15 | 2015-04-16 | 135 | $7.58 | $1.0K | 18,703 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-15 | 2015-04-16 | 7,920 | $7.58 | $60.0K | 1,096,575 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-14 | 2015-04-16 | 168 | $7.78 | $1.3K | 18,838 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-14 | 2015-04-16 | 9,832 | $7.78 | $76.5K | 1,104,495 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2015-03-20 | 2015-03-24 | 350,000 | — | $0 | 2,216,935 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 2,164,305 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 6,111,968 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 737,422 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 7,252,144 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 92,105 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 165,790 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 2,827 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 12,578 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 104,247 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 36,913 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 102,282 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 1,570 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 7,252,144 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 2,164,305 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 6,111,968 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 737,422 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 165,790 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 92,105 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 1,570 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 2,827 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 102,282 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 36,913 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 104,247 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 12,578 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 165,790 | $8.54 | $1.42M | 3,122,774 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-26 | 2,921,064 | — | $0 | 2,921,064 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 92,105 | $8.54 | $786.6K | 3,013,169 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-11-26 | 70,000 | $14.00 | $980.0K | 3,091,642 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 101,132 | $14.00 | $1.42M | 3,021,642 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 56,185 | $14.00 | $786.6K | 2,956,984 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-26 | 46,309 | — | $0 | 46,309 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 958 | $14.00 | $13.4K | 46,921 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 2,827 | $8.54 | $24.1K | 49,748 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 1,725 | $14.00 | $24.1K | 48,023 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 1,570 | $8.54 | $13.4K | 47,879 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 56,185 | $14.00 | $786.6K | 2,956,985 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 165,790 | $8.54 | $1.42M | 3,122,775 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 101,132 | $14.00 | $1.42M | 3,021,643 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-12-10 | 70,000 | $14.00 | $980.0K | 3,091,643 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-12-10 | 2,921,065 | — | $0 | 2,921,065 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 92,105 | $8.54 | $786.6K | 3,013,170 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 958 | $14.00 | $13.4K | 46,923 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-12-10 | 46,311 | — | $0 | 46,311 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 1,725 | $14.00 | $24.1K | 48,025 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 2,827 | $8.54 | $24.1K | 49,750 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 1,570 | $8.54 | $13.4K | 47,881 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 6,250 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 22,306 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 3,006,132 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 620,776 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 1,272,607 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 9,443 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 4,606 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion | 2014-10-21 | 2014-10-21 | 1,893,383 | — | $0 | 1,893,383 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 248,159 | $11.00 | $2.73M | 2,141,542 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion | 2014-10-21 | 2014-10-21 | 14,049 | — | $0 | 14,049 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 1,841 | $11.00 | $20.3K | 15,890 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 500,000 | $20.00 | $10.00M | 2,566,935 | SEC↗ |
| VCYT VERACYTE, INC. | J Other | 2014-09-10 | 2014-09-12 | 300,000 | — | $0 | 2,763,294 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h deriv | 2014-08-18 | 2014-08-18 | 186,828 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise deriv | 2014-08-18 | 2014-08-18 | 67,755 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 925,479 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 436,485 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 3,238 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 6,866 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise deriv | 2014-08-18 | 2014-08-18 | 502 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h deriv | 2014-08-18 | 2014-08-18 | 1,386 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h | 2014-08-18 | 2014-08-18 | 37,224 | $16.00 | $595.6K | 1,579,323 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise | 2014-08-18 | 2014-08-18 | 67,755 | $8.79 | $595.6K | 1,616,547 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-18 | 1,548,792 | — | $0 | 1,548,792 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h | 2014-08-18 | 2014-08-18 | 277 | $16.00 | $4.4K | 11,715 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-18 | 11,490 | — | $0 | 11,490 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise | 2014-08-18 | 2014-08-18 | 502 | $8.79 | $4.4K | 11,992 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 579,630 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 820,320 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 657,192 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 8,792 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 1,165 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 7,043 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 2,057,142 | — | $0 | 2,057,142 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 419,744 | $8.00 | $3.36M | 2,476,886 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-07 | 2014-05-07 | 0 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-07 | 2014-05-07 | 21,250 | — | $0 | 1,973,389 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 60,576 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 60,576 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 755,263 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 486,316 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 3,882 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 60,576 | $5.16 | $312.6K | 1,969,689 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 39,063 | $8.00 | $312.5K | 1,930,626 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 60,576 | $5.16 | $312.6K | 1,991,202 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-01 | 2014-05-05 | 1,909,113 | — | $0 | 1,909,113 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 39,063 | $8.00 | $312.5K | 1,952,139 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-01 | 2014-05-05 | 9,208 | — | $0 | 9,208 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 7,313,241 | $14.00 | $102.39M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 78,369 | $14.00 | $1.10M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 27,500 | $14.00 | $385.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 50,743 | $14.00 | $710.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 2,972,678 | $14.00 | $41.62M | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 435,663 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 10,661 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 15,799 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 7,430 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 926,321 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 625,065 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion | 2014-03-17 | 2014-03-17 | 33,890 | — | $0 | 33,890 | SEC↗ |
| AKAO Achaogen Inc | C Conversion | 2014-03-17 | 2014-03-17 | 1,987,049 | — | $0 | 1,987,049 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-14 | 23,317 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,367,020 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-14 | 13,058 | $14.00 | $182.8K | 50,743 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-14 | 23,317 | $7.84 | $182.8K | 63,801 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-14 | 765,532 | $14.00 | $10.72M | 2,972,678 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-14 | 1,367,020 | $7.84 | $10.72M | 3,738,210 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 476,464 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 156 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 21,041 | — | $0 | 21,041 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 21,041 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 1,276,243 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 3,535 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 156 | — | $0 | 156 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 9,469 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 13,004 | — | $0 | 13,004 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 1,752,707 | — | $0 | 1,752,707 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-16 | 2014-01-17 | 2,230 | $6.56 | $14.6K | 34,907 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-16 | 2014-01-17 | 204,315 | $6.56 | $1.34M | 3,590,931 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-15 | 2014-01-17 | 1,010 | $6.01 | $6.1K | 37,137 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-15 | 2014-01-17 | 92,445 | $6.01 | $555.6K | 3,795,246 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 590,403 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 356,111 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 549,833 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 2,283,114 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 352,351 | — | $0 | 352,351 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 6,071 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 9,378 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 38,941 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 10,068 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 6,008 | — | $0 | 6,008 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion | 2013-11-19 | 2013-11-19 | 54,390 | — | $0 | 54,390 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion | 2013-11-19 | 2013-11-19 | 3,189,058 | — | $0 | 3,189,058 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 680,972 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 2,382,322 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 17,677 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 5,053 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion | 2013-11-04 | 2013-11-04 | 22,730 | — | $0 | 22,730 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion | 2013-11-04 | 2013-11-04 | 3,063,294 | — | $0 | 3,063,294 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion deriv | 2013-09-30 | 2013-09-30 | 19,006 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion deriv | 2013-09-30 | 2013-09-30 | 1,114,327 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion | 2013-09-30 | 2013-09-30 | 1,114,327 | — | $0 | 1,114,327 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion | 2013-09-30 | 2013-09-30 | 19,006 | — | $0 | 19,006 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 4,233 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 2,899 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 7,407 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 394,969 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 270,568 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 225,913 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 894,120 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 394,969 | — | $0 | 430,516 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 7,407 | — | $0 | 14,920 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 270,568 | — | $0 | 701,084 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 4,233 | — | $0 | 4,614 | SEC↗ |
| RGDO Regado Biosciences Inc | P Buy | 2013-08-27 | 2013-08-28 | 750,000 | $4.00 | $3.00M | 2,571,117 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 225,913 | — | $0 | 1,821,117 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 894,120 | — | $0 | 1,595,204 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 2,899 | — | $0 | 7,513 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-16 | 331,873 | $6.03 | $2.00M | 1,897,336 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-16 | 7,333 | $6.03 | $44.2K | 7,333 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-16 | 988,285 | $6.03 | $5.96M | 988,285 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-31 | 331,873 | $6.03 | $2.00M | 1,857,036 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-31 | 7,333 | $6.03 | $44.2K | 7,333 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-31 | 988,285 | $6.03 | $5.96M | 988,285 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 70,042 | — | $0 | 70,042 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-02 | 1,786,012 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 8,346 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-02 | 30,462 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 1,193 | — | $0 | 1,193 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 489,320 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-02 | 280,923 | $14.00 | $3.93M | 2,066,935 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-02 | 1,786,012 | — | $0 | 1,786,012 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-02 | 30,462 | — | $0 | 30,462 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-02 | 4,791 | $14.00 | $67.1K | 35,253 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-20 | 2013-06-24 | 10,516 | $5.01 | $52.7K | 3,887,691 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-20 | 2013-06-24 | 114 | $5.01 | $571 | 38,147 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-19 | 2013-06-20 | 22,423 | $5.37 | $120.4K | 3,898,207 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-19 | 2013-06-20 | 244 | $5.37 | $1.3K | 38,261 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-18 | 2013-06-20 | 32,855 | $5.40 | $177.4K | 3,920,630 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-18 | 2013-06-20 | 359 | $5.40 | $1.9K | 38,505 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-17 | 2013-06-18 | 87,812 | $5.40 | $474.2K | 3,953,485 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-17 | 2013-06-18 | 959 | $5.40 | $5.2K | 38,864 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-14 | 2013-06-18 | 38,897 | $5.03 | $195.7K | 4,041,297 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-14 | 2013-06-18 | 425 | $5.03 | $2.1K | 39,823 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-11 | 2013-06-13 | 5,337 | $5.00 | $26.7K | 4,080,194 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-11 | 2013-06-13 | 59 | $5.00 | $295 | 40,248 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-04 | 2013-06-05 | 159,192 | $64.58 | $10.28M | 2,581,745 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-04 | 2013-06-05 | 2,779 | $64.58 | $179.5K | 44,034 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-16 | 2013-05-17 | 21,276 | $4.50 | $95.7K | 4,085,531 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-16 | 2013-05-17 | 232 | $4.50 | $1.0K | 40,307 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-15 | 2013-05-17 | 22,966 | $4.70 | $107.9K | 4,106,807 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-15 | 2013-05-17 | 251 | $4.70 | $1.2K | 40,539 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-15 | 2013-04-17 | 71,578 | $6.62 | $473.8K | 7,313,241 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-15 | 2013-04-17 | 23,210 | $6.62 | $153.7K | 2,371,190 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-10 | 2013-04-10 | 4,832 | $6.72 | $32.5K | 7,384,819 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-10 | 2013-04-10 | 1,567 | $6.72 | $10.5K | 2,394,400 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-09 | 2013-04-10 | 35,114 | $6.71 | $235.6K | 7,389,651 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-09 | 2013-04-10 | 11,386 | $6.71 | $76.4K | 2,395,967 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-08 | 2013-04-10 | 37,676 | $6.52 | $245.6K | 7,424,765 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-08 | 2013-04-10 | 12,217 | $6.52 | $79.7K | 2,407,353 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 893 | $5.49 | $4.9K | 40,484 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 1,743 | $5.49 | $9.6K | 78,369 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 13,490 | $5.35 | $72.2K | 7,462,441 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 4,374 | $5.35 | $23.4K | 2,419,570 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 5,510 | $5.22 | $28.8K | 2,423,944 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 16,995 | $5.22 | $88.7K | 7,475,931 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 92 | $5.22 | $480 | 41,377 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 182 | $5.22 | $950 | 80,112 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 7,925 | $5.19 | $41.1K | 2,429,454 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 24,442 | $5.19 | $126.9K | 7,492,926 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 134 | $5.19 | $695 | 41,469 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 261 | $5.19 | $1.4K | 80,294 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 8,020 | $5.16 | $41.4K | 2,437,379 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 24,736 | $5.16 | $127.6K | 7,517,368 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 135 | $5.16 | $697 | 41,603 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 265 | $5.16 | $1.4K | 80,555 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 9,636 | $5.28 | $50.9K | 2,445,399 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 29,719 | $5.28 | $156.9K | 7,542,104 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 163 | $5.28 | $861 | 41,738 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 318 | $5.28 | $1.7K | 80,820 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 5,020 | $5.36 | $26.9K | 2,455,035 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 15,480 | $5.36 | $83.0K | 7,571,823 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 85 | $5.36 | $456 | 41,901 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 166 | $5.36 | $890 | 81,138 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 7,733 | $5.40 | $41.8K | 2,460,055 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 23,848 | $5.40 | $128.8K | 7,587,303 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 131 | $5.40 | $707 | 41,986 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 256 | $5.40 | $1.4K | 81,304 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 6,346 | $5.38 | $34.1K | 2,467,788 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 19,569 | $5.38 | $105.3K | 7,611,151 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 107 | $5.38 | $576 | 42,117 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 210 | $5.38 | $1.1K | 81,560 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 4,118 | $5.34 | $22.0K | 2,474,134 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 12,700 | $5.34 | $67.8K | 7,630,720 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 70 | $5.34 | $374 | 42,224 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 136 | $5.34 | $726 | 81,770 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 5,154 | $5.32 | $27.4K | 2,478,252 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 15,892 | $5.32 | $84.5K | 7,643,420 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 88 | $5.32 | $468 | 42,294 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 171 | $5.32 | $910 | 81,906 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 12,701 | $5.22 | $66.3K | 2,483,406 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 39,168 | $5.22 | $204.5K | 7,659,312 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 215 | $5.22 | $1.1K | 42,382 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 420 | $5.22 | $2.2K | 82,077 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-06 | 2013-03-06 | 1,651 | $24.51 | $40.5K | 46,813 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-06 | 2013-03-06 | 98,349 | $24.51 | $2.41M | 2,740,937 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 65 | $5.06 | $329 | 42,597 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 127 | $5.06 | $643 | 82,497 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 3,839 | $5.06 | $19.4K | 2,496,107 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 11,841 | $5.06 | $59.9K | 7,698,480 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-05 | 2013-03-06 | 2,132 | $24.69 | $52.6K | 48,464 | SEC↗ |